MEI Pharma Board Rejects Anson/Cable Car Unsolicited Bid, Reaffirms Infinity Merger

Lite Strategy, Inc.

Board unanimously rejects unsolicited, non-binding proposal from Anson Advisors and Cable Car Capital as undervaluing the Company.
Proposal was at a significant discount to MEI's cash position; Board sees no basis for discussions on an alternative transaction.
Board reaffirms recommendation for pending merger with Infinity; combined pipeline of three clinical-stage programs.
Key clinical data from combined pipeline expected in 6-24 months, including from two programs by year-end.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.